|
2008-01-08 Intercell s results on a novel pneumococcal protein-based vaccine published in the Journal.pdf
|
pdf
|
210 kB
|
|
2008-01-16 Intercell and PATH Announce New Collaboration for a Vaccine against Malaria.pdf
|
pdf
|
235 kB
|
|
2008-01-16 Manufacturer s Licence for Future Commercial Manufacturing of Vaccine Against Japanese Encephalitis.pdf
|
pdf
|
194 kB
|
|
2008-02-06 Intercell s therapeutic Hepatitis C vaccine meets primary endpoints in Phase II.pdf
|
pdf
|
201 kB
|
|
2008-02-14 Vaccine formulated with Intercell s adjuvant IC31 R part of a broader collaboration to fight Tuberculosis.pdf
|
pdf
|
204 kB
|
|
2008-02-27 ICLL completes Phase I clinical trial for an improved seasonal Influenza vaccine formulated with IC31 R .pdf
|
pdf
|
211 kB
|
|
2008-02-29 Licensure application for JE vaccine submitted to TGA in Australia.pdf
|
pdf
|
218 kB
|
|
2008-03-03 Q4 Report.pdf
|
pdf
|
250 kB
|
|
2008-04-15 ICLL s investigational vaccine against JE shows excellent safety and immunogenicity in Phase II trials in children.pdf
|
pdf
|
194 kB
|
|
2008-04-21 Strong alliance to fight fungal infections.pdf
|
pdf
|
213 kB
|
|
2008-04-24 Intercell receives The Vaccine Industry Excellence Award.pdf
|
pdf
|
196 kB
|
|
2008-05-12 Intercell AG to acquire Iomai Corporation.pdf
|
pdf
|
240 kB
|
|
2008-05-13 Q1 Report.pdf
|
pdf
|
282 kB
|
|
2008-06-05 Intercell granted Early Termination of HSR Waiting Period for Iomai-Acquisition.pdf
|
pdf
|
207 kB
|
|
2008-06-12 Iomai Announces Publication in The Lancet.pdf
|
pdf
|
240 kB
|
|
2008-06-13 Milestone payment triggered by initiation of further clinical trial for Flu vaccine with IC31.pdf
|
pdf
|
185 kB
|
|
2008-06-19 Licensure application for JE vaccine submitted to Canadian Division of Biologics and Genetic Therapies Directorate of Health.pdf
|
pdf
|
218 kB
|
|
2008-07-11 IOMAI Acquisition granted clearance by US Authorities.pdf
|
pdf
|
210 kB
|
|
2008-08-01 IOMAI shareholders approve acquisition by Intercell.pdf
|
pdf
|
201 kB
|
|
2008-08-06 Intercell AG closes Acquisition of Iomai Corporation.pdf
|
pdf
|
227 kB
|
|
2008-08-06 Intercell AG closes Acquisition of Iomai Corporation.pdf
|
pdf
|
227 kB
|
|
2008-08-18 Q2 Report.pdf
|
pdf
|
236 kB
|
|
2008-08-21 US Defense Logistics Agency announces plans to enter into supply contract to purchase JE vaccine.pdf
|
pdf
|
214 kB
|
|
2008-08-28 Initiation of further Phase II clinical trial of V710 an investigational vaccine to prevent S. aureus infection.pdf
|
pdf
|
212 kB
|
|
2008-09-03 Favourable six months follow-up results from ICLL s Phase II therapeutic Hepatitis C program.pdf
|
pdf
|
197 kB
|
|
2008-09-25 Intercell-Novartis Vaccine alliance.pdf
|
pdf
|
184 kB
|
|
2008-10-20 JEV Approvals in United States Europe and Australia remain on track for 2008.pdf
|
pdf
|
193 kB
|
|
2008-11-11 Q3 Report.pdf
|
pdf
|
221 kB
|
|
2008-12-04 World Economic Forum selects Intercell as Technology Pioneer 2009.pdf
|
pdf
|
208 kB
|
|
2008-12-10 ICLL Reports Study Showing JE Vaccine is Safe and Immunogenic in Children.pdf
|
pdf
|
225 kB
|
|
2008-12-10 USD 12.5 m funding for the development of ICLL s vaccine patch system for Pandemic Influenza from HHS.pdf
|
pdf
|
186 kB
|
|
2008-12-11 Intercell AG wins the Scrip Award for Biotech Company of the Year.pdf
|
pdf
|
171 kB
|
|
2008-12-12 Australia first country to receive positive recommendation for ICLL s Vaccine to Prevent JE.pdf
|
pdf
|
192 kB
|
|
2008-12-15 Intercell receives CHMP positive opinion for the approval of IXIARO R in Europe.pdf
|
pdf
|
196 kB
|
|
2008-12-19 Intercell update on technology partnerships.pdf
|
pdf
|
201 kB
|
|
2008-12-29 Product Development Update.pdf
|
pdf
|
188 kB
|
